JJ

Jose Joseph

Active Director Director DIN 02674471
DIN 02674471 First appointment Jul 2009 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jul 2009
Shareholding value Locked Premium profile

About Jose Joseph

Jose Joseph has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Lycus Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02674471
Primary Designation Director
First Appointment 06 Jul 2009
Oldest Company Age 17 yrs

Current companies

Company Designation Appointment Founded Status
Lycus Pharma Private Limited U52311KL2009PTC024412
Director 06 Jul 2009 2009 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lycus Pharma Private Limited
Premium access

Shareholding and investment profile for Jose Joseph

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jose Joseph

Jose Joseph has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Lycus Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Jose Joseph is associated with 1 company as Director.

Jose Joseph has expertise in General Business.

Jose Joseph has 17 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available